Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Leukemia & Lymphoma
|
April 28, 2000
CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells
A W Tong, B Seamour, J Chen, et al.
Cancer Gene Therapy
|
August 21, 2007
A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients
J Nemunaitis, N Senzer, S Sarmiento, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer
A W Tong, M H Papayoti, G Netto, et al.
Cancer Research
|
September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody
A W Tong, J Lee, R M Wang, et al.
Cancer Gene Therapy
|
October 25, 2008
MicroRNA profile analysis of human prostate cancers
A W Tong, P Fulgham, C Jay, et al.
American Journal of Clinical Oncology
|
October 20, 2000
Cellular immune profile of patients with advanced cancer before and after taxane treatment
A W Tong, B Seamour, J M Lawson, et al.
Cell Proliferation
|
December 30, 1999
Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component
C Greco, F Ameglio, F Alvino, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Leukemia & Lymphoma
|
April 28, 2000
CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells
A W Tong, B Seamour, J Chen, et al.
Cancer Gene Therapy
|
August 21, 2007
A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients
J Nemunaitis, N Senzer, S Sarmiento, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer
A W Tong, M H Papayoti, G Netto, et al.
Cancer Research
|
September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody
A W Tong, J Lee, R M Wang, et al.
Cancer Gene Therapy
|
October 25, 2008
MicroRNA profile analysis of human prostate cancers
A W Tong, P Fulgham, C Jay, et al.
American Journal of Clinical Oncology
|
October 20, 2000
Cellular immune profile of patients with advanced cancer before and after taxane treatment
A W Tong, B Seamour, J M Lawson, et al.
Cell Proliferation
|
December 30, 1999
Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component
C Greco, F Ameglio, F Alvino, et al.
Page
of 3